Sana Belkahla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sana Belkahla has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Insha Nahvi
Department of Basic Sciences, Preparatory Year Deanship, King Faisal University, Al Ahsa 31982, Saudi Arabia
1 shared publication Irum Nahvi
College of Computer Engineering and Science
1 shared publicationNidhal Ben Amor
Department of Basic Sciences, Preparatory Year Deanship, King Faisal University, Al Hofuf, Saudi Arabia
1 shared publicationSupratim Biswas
Department of Basic Sciences, Preparatory Year Deanship, King Faisal University, Al Hofuf, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 12 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 29447
Dichloroacetate enhances Chemo-sensitivity in wild-type P53 breast cancer cells by modulating ABCG2 and NKG2DL
The chemotherapy drug called Adriamycin, often known as doxorubicin (Dox), is used to treat BC, including late stages. However, the emergence of resistance may reduce the efficacy of Dox in the treatment of BC. The objective of the current work is to assess how the stress ligands MICA, MICB, and ULBP1 and the expression of ABCG2 are affected by dichloroacetate (DCA). To determine the chemosensitivity of breast cancer cells, an MTT assay was performed. P-53 and ERK5 genes were silenced by Si-RNA, and gene expression level was monitored by qRT-PCR and confirmed by immunoblotting. When compared to untreated cells, our data show a significant decrease in the viability of all cell lines following a 24-hour incubation period with 5 µM of Dox in conjunction with 1 or 5 mM of DCA. The cell line MCF7 exhibited the highest rate of inhibition, followed by MDA-MB-231 and T47D. In addition, we found that DCA significantly decreases the level of ABCG2 mRNA in MCF7 cells. However, this effect was reversed in T47D and MDA-MB-231 cells. The expression of NKG2DL, MICA/B, and ULBP has also been studied. The findings indicate that DCA significantly increases the mRNA of MICA/B and ULBP1 exclusively in cells that express normal p53. ABCG2 mRNA expression is markedly upregulated in MCF7 cells upon P53 and ERK5 downregulation. Collectively, these findings showed that DCA increases the susceptibility of breast cancer cells to Dox through the upregulation of NKG2DL and the downregulation of ABCG2 expression via a p53-ERK5 dependent pathway.
- 12 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 29447
Open AccessDichloroacetate enhances Chemo-sensitivity in wild-type P53 breast cancer cells by modulating ABCG2 and NKG2DL
The chemotherapy drug called Adriamycin, often known as doxorubicin (Dox), is used to treat BC, including late stages. However, the emergence of resistance may reduce the efficacy of Dox in the treatment of BC. The objective of the current work is to assess how the stress ligands MICA, MICB, and ULBP1 and the expression of ABCG2 are affected by dichloroacetate (DCA). To determine the chemosensitivity of breast cancer cells, an MTT assay was performed. P-53 and ERK5 genes were silenced by Si-RNA, and gene expression level was monitored by qRT-PCR and confirmed by immunoblotting. When compared to untreated cells, our data show a significant decrease in the viability of all cell lines following a 24-hour incubation period with 5 µM of Dox in conjunction with 1 or 5 mM of DCA. The cell line MCF7 exhibited the highest rate of inhibition, followed by MDA-MB-231 and T47D. In addition, we found that DCA significantly decreases the level of ABCG2 mRNA in MCF7 cells. However, this effect was reversed in T47D and MDA-MB-231 cells. The expression of NKG2DL, MICA/B, and ULBP has also been studied. The findings indicate that DCA significantly increases the mRNA of MICA/B and ULBP1 exclusively in cells that express normal p53. ABCG2 mRNA expression is markedly upregulated in MCF7 cells upon P53 and ERK5 downregulation. Collectively, these findings showed that DCA increases the susceptibility of breast cancer cells to Dox through the upregulation of NKG2DL and the downregulation of ABCG2 expression via a p53-ERK5 dependent pathway.
- Open Access
- 9 September 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 10, 991330
Advances and development of prostate cancer, treatment, and strategies: A systemic review
The most common type of cancer in the present-day world affecting modern-day men after lung cancer is prostate cancer. Prostate cancer remains on the list of top three cancer types claiming the highest number of male lives. An estimated 1.4 million new cases were reported worldwide in 2020. The incidence of prostate cancer is found predominantly in the regions having a high human development index. Despite the fact that considerable success has been achieved in the treatment and management of prostate cancer, it remains a challenge for scientists and clinicians to curve the speedy advancement of the said cancer type. The most common risk factor of prostate cancer is age; men tend to become more vulnerable to prostate cancer as they grow older. Commonly men in the age group of 66 years and above are the most vulnerable population to develop prostate cancer. The gulf countries are not far behind when it came to accounting for the number of individuals falling prey to the deadly cancer type in recent times. There has been a consistent increase in the incidence of prostate cancer in the gulf countries in the past decade. The present review aims at discussing the development, diagnostics via machine learning, and implementation of treatment of prostate cancer with a special focus on nanotherapeutics, in the gulf countries.
- 9 September 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 10, 991330
Open AccessAdvances and development of prostate cancer, treatment, and strategies: A systemic review
The most common type of cancer in the present-day world affecting modern-day men after lung cancer is prostate cancer. Prostate cancer remains on the list of top three cancer types claiming the highest number of male lives. An estimated 1.4 million new cases were reported worldwide in 2020. The incidence of prostate cancer is found predominantly in the regions having a high human development index. Despite the fact that considerable success has been achieved in the treatment and management of prostate cancer, it remains a challenge for scientists and clinicians to curve the speedy advancement of the said cancer type. The most common risk factor of prostate cancer is age; men tend to become more vulnerable to prostate cancer as they grow older. Commonly men in the age group of 66 years and above are the most vulnerable population to develop prostate cancer. The gulf countries are not far behind when it came to accounting for the number of individuals falling prey to the deadly cancer type in recent times. There has been a consistent increase in the incidence of prostate cancer in the gulf countries in the past decade. The present review aims at discussing the development, diagnostics via machine learning, and implementation of treatment of prostate cancer with a special focus on nanotherapeutics, in the gulf countries.